{"id":"intermittent-pivotal-l-ab","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL1821846","moleculeType":"Small molecule","molecularWeight":"676.71"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This inhibition prevents the degradation of beta-lactam antibiotics, allowing them to be effective against bacterial infections. By preserving the activity of these antibiotics, intermittent pivotal βL-AB helps to combat bacterial infections that would otherwise be resistant to treatment.","oneSentence":"Intermittent pivotal βL-AB works by inhibiting the beta-lactamase enzyme.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:49:20.351Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bacterial infections caused by beta-lactamase-producing bacteria"}]},"trialDetails":[{"nctId":"NCT05681442","phase":"PHASE4","title":"Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-13","conditions":"Sepsis","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IID control group"],"phase":"marketed","status":"active","brandName":"intermittent pivotal βL-AB","genericName":"intermittent pivotal βL-AB","companyName":"Assistance Publique - Hôpitaux de Paris","companyId":"assistance-publique-h-pitaux-de-paris","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Intermittent pivotal βL-AB works by inhibiting the beta-lactamase enzyme. Used for Treatment of bacterial infections caused by beta-lactamase-producing bacteria.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}